Growing community of inventors

Cincinnati, OH, United States of America

Joseph L Clark

Average Co-Inventor Count = 2.12

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 12

Joseph L ClarkDaniel Newton Woo (2 patents)Joseph L ClarkCharles L Rosen (2 patents)Joseph L ClarkSteven Cutright (2 patents)Joseph L ClarkJoseph P Broderick (2 patents)Joseph L ClarkTodd J Crocco (2 patents)Joseph L ClarkFred R Beyette, Jr (1 patent)Joseph L ClarkAnindya Majumder (1 patent)Joseph L ClarkJames J Caffery, Jr (1 patent)Joseph L ClarkPrashant Bhadri (1 patent)Joseph L ClarkGail Pyne-Geithman (1 patent)Joseph L ClarkChad J Morgan (1 patent)Joseph L ClarkJoseph L Clark (7 patents)Daniel Newton WooDaniel Newton Woo (4 patents)Charles L RosenCharles L Rosen (3 patents)Steven CutrightSteven Cutright (2 patents)Joseph P BroderickJoseph P Broderick (2 patents)Todd J CroccoTodd J Crocco (2 patents)Fred R Beyette, JrFred R Beyette, Jr (6 patents)Anindya MajumderAnindya Majumder (5 patents)James J Caffery, JrJames J Caffery, Jr (2 patents)Prashant BhadriPrashant Bhadri (1 patent)Gail Pyne-GeithmanGail Pyne-Geithman (1 patent)Chad J MorganChad J Morgan (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Other (4 from 832,891 patents)

2. Tricerapro Holding, LLC (2 from 2 patents)

3. University of Cincinnati (1 from 532 patents)


7 patents:

1. 11690858 - Neuroprotective mixture for mitigating the harmful effects of ischemic stroke

2. 10874151 - Wearable cooling system

3. 10864221 - Neuroprotective mixture for mitigating the harmful effects of ischemic stroke

4. 8707499 - Apparatus for detecting contaminates on a hard surface

5. 8027814 - Methods for assessing a condition by analyzing blood in cerebrospinal fluid

6. 7208288 - Methods for enhancing the lysis of coagulated blood with apolipoprotein E2 phenotype

7. 7135305 - Methods for controlling the lysis of coagulated blood with apolipoprotein e4 phenotype

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/2/2026
Loading…